Introduction
============

It is well known that oxidative stress caused by reactive oxygen and free radicals is involved in pathogenesis of various kinds of diseases such as diabetes mellitus, hypertension, hyperlipidemia, arteriosclerosis, periodontal diseases, Alzheimer's disease, Parkinson's disease, and cancers.^([@B1])^ However, no highly sensitive biomarkers have been developed to evaluate the condition of oxidative stress and the treatment effect of antioxidants in the clinical setting.

To this end, we have been interested in albumin, one of the major antioxidants in human serum; albumin is capable of scavenging hydroxyl radicals with its reduced (-SH) cysteine residue (Cys34). As a result, the thiol group of Cys34 in albumin exists in either a reduced (-SH) or oxidized (-S-S-) form; the former is called reduced albumin or human mercaptalbumin (HMA) and the latter, oxidized albumin or human nonmercaptalbumin (HNA). Because albumin is distributed widely in intra- and extra-vascular spaces, the oxidation of albumin reportedly reflects the status of oxidative stress in the whole body. In healthy adults, approximately 70--80% of serum albumin has been shown to be HMA, and the rest, HNA.^([@B2])^ Although these findings suggest that HMA and HNA could be a reliable blood marker for oxidative stress, the measuring method of HMA and HNA has been problematic, being extremely time-consuming.^([@B3],[@B4])^ Thus, we have developed a novel method using anion-exchange HPLC system, rendering those measurements more rapid and reliable.

Using this novel method, we evaluated HNA in the subjects who had undergone a general health examination. Then, because it has been reported that some clinical parameters in the blood, such as C-reactive protein (CRP),^([@B5])^ γ-glutamyltransferase (GGT)^([@B6])^ or uric acid (UA),^([@B7])^ might be indicative of oxidative stress, we examined whether these parameters would be really associated with oxidative stress and could predict its status.

Methods
=======

Subjects and data collection
----------------------------

Participants were recruited at the time of a health examination performed at the University of Tokyo Hospital between June and July in 2016. Venous blood sampling after an overnight fast was performed as part of a health check-up. Chemistry and complete blood count test were performed. This study was carried out in accordance with the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Institutional Research Ethics Committee of the Faculty of Medicine at the University of Tokyo. Written informed consent was obtained for the use of samples.

Measurement of HMA and HNA
--------------------------

We used the LabSolutions system (Shimadzu Co., Ltd., Kyoto, Japan), consisting of a degasser (DGU20A3R), two pumps (LC-20AT), an auto-sampler (SIL30AC), a thermostatic oven (CTO-20AC), a fluorescence detector (RF-20Axs) and a system controller (CBM-20A).

The gel and the column for the analysis of HMA and HNA were made using the following method. A polyvinyl alcohol cross-linked gel (9 µm in diameter) (Asahipak GS-520; Asahi Kasei Co., Ltd., Tokyo, Japan) was dried in a vacuum for more than 16 h and then suspended in 10 ml of dimethyl sulfoxide (Tokyo Chemical Industry Co., Ltd., Tokyo, Japan) per 1 g of dried gel. Next, 20 mmol of epichlorohydrin for each 1 g of dried gel was added to suspend the gel; the reaction was allowed to proceed for 20 h at 30°C.

The activated gel was filtrated and reacted with a 10% aqueous solution of diethyl amine (Wako Pure Chem. Ind., Ltd., Osaka, Japan) for 20 h. The synthesized anion-exchange gel was packed in a stainless column (50 × 7.6 mm I.D.).

Using the above system and column, the optimal HPLC conditions, which consisted of the compositions and concentrations of eluents A and B, pH, flow rate, gradient condition of the eluents (ethanol concentration, magnesium concentration, and pH), temperature of the thermostatic oven, and sample with the goal of establishing a rapid and convenient method of measuring HMA and HNA. All the reagents were either HPLC grade or a special grade (Wako Pure Chem.). The conditions for fluorescence detection were the same as those previously reported by Hayashi *et al.*, and the excitation and emission wavelengths were 280 nm and 340 nm, respectively.^([@B8],[@B9])^

The conventional method using anion-exchange chromatography developed by Era *et al.*^([@B4])^ uses a three-step gradient program of 1%, 3%, and 10% ethanol concentrations for eluents, and the analysis conditions are complicated; the method takes about 1 h to perform, including time for column equilibration. And it is not applicable in clinical settings requiring the measurement of large numbers of samples simultaneously. Thus, we established a simple and rapid HPLC method suitable for clinical measurements with an analytical time of only 12 min per test. The repeatability (within-day variability) and reproducibility (day-to-day variability) were 0.30% and 0.27% (CV), respectively.

Statistical analysis
--------------------

Data were expressed as mean ± SD. Mann-Whitney *U* test was used to make a comparison between male and female. Regression equations and correlation coefficients between HNA and the categorical variables were determined by Spearman's rank correlation coefficient. A *p* value \<0.05 was considered statistically significant.

Ethical approval
----------------

This study was carried out in accordance with the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Institutional Research Ethics Committee of the Faculty of Medicine at the University of Tokyo (Approval number 2565-(2)). Written informed consent was obtained for the use of samples.

Results and Discussion
======================

Characteristics of the subjects and their serum HNA levels
----------------------------------------------------------

Characteristics of the subjects are shown in Table [1](#T1){ref-type="table"}. The mean age was 63.1 ± 9.9, suggesting that the cohort analyzed consisted of relatively older subjects. Judged by the measured mean values of various parameters, the enrolled subjects were assumed to be essentially healthy. In those subjects, the mean serum HNA level was 25.1 ± 3.0%. Serum HNA levels in male were 25.1 ± 3.1%, and not different from those in female (25.0 ± 3.2%). On the other hand, there was a positive correlation between HNA and age, as previously reported (Fig. [1](#F1){ref-type="fig"}A).^([@B10])^ The previous report indicated that approximately 20--30% of serum albumin was HNA,^([@B2])^ and our current result obtained with the applicants for a health examination is in line with this previous finding.

Relationships between serum HNA levels and various clinical parameters
----------------------------------------------------------------------

Then, the relationships between serum HNA levels and various clinical parameters were evaluated, and the results are shown in Table [2](#T2){ref-type="table"}. The significant positive correlation with HNA was observed in pulse pressure (PP), AST, LDH, BUN, Cre, systolic blood pressure (SBP), UA, WBC, BMI, TG, and HbA1c (Table [2](#T2){ref-type="table"} and Fig. [1](#F1){ref-type="fig"}B--L). The gender differences regarding the correlation with HNA are noted in AST, Cre, and UA.

Although CRP, GGT and Fe have been previously shown to be associated with oxidative stress, there were no links observed between those factors and HNA. Because GGT has a gender difference, its link with HNA was analyzed in male and in female, respectively, but the close link was not found. On the other hand, a significant correlation was observed between GGT and Fe (rs = 0.3802, *p* = 0.0014) but not between CRP and GGT, and CRP and Fe. Thus, CRP, GGT and Fe should be re-evaluated as a marker for oxidative stress, importantly with measurement of total antioxidant capacity.^([@B11])^

Roles of oxidative stress in hypertension have been demonstrated.^([@B12])^ In line with this report, PP and SBP among blood pressure-related parameters correlated strongly with HNA, while DBP did not. Of note is the report that the treatment with anti-oxidant, vitamin C, lowered SBP and PP but not DBP in the elderly.^([@B13])^ The current result may be in line with this previous report. Nonetheless, it should be clarified why oxidative stress correlated only with SBP.

Obesity reportedly increases oxidative stress especially in female,^([@B14])^ and notably BMI correlated well with HNA similarly in male and in female in the current study (Table [2](#T2){ref-type="table"}). Regarding blood pressure and obesity, it should be elucidated whether their associations with oxidative stress would be cause or effect.

As a daily habit, HNA was not different between drinker and non-drinker (Table [3](#T3){ref-type="table"}). Although smoking history did not affect HNA, either, whether present smoking might increase HNA was not known because of the small number of subject with smoking (*n* = 5; Table [3](#T3){ref-type="table"}).

Highly positive correlations were observed between HNA and BUN or Cre (Table [2](#T2){ref-type="table"}, Fig. [1](#F1){ref-type="fig"}E and F), suggesting a close correlation between oxidative stress and renal functions. The rapid alteration of redox state of human serum albumin was previously reported before and after hemodialysis.^([@B15])^ Furthermore, HMA was reportedly decreased in patients with chronic kidney diseases.^([@B16])^ Thus, renal functions may be one of the major determinants of serum HNA levels and hence the status of oxidative stress.

UA is formed from xanthine as one of purine bases by xanthine oxidase (XO), when nucleic acid is metabolized. Thus, hyperuricemia may be often associated with high activity of XO, and the abundant XO could cause the production of free radicals. As a result, hyperuricemia could lead to active generation of oxidative stress.^([@B17])^ In contrast, because UA can work as a scavenger against reactive oxygen, UA may play a role as an antioxidant, suggesting that hyperuricemia could cause reduction of reactive oxygen.^([@B18])^ Thus, there have been antithetic concepts whether higher UA levels could be associated with increased or decreased oxidative stress. In the current study, although the significant positive correlation was observed between HNA and UA, the strong positive correlation was determined only in female but not in male (Table [2](#T2){ref-type="table"} and Fig. [1](#F1){ref-type="fig"}H), suggesting that higher UA levels may be associated with increased oxidative stress in female but not in male. Of interest is the fact that higher UA levels reportedly had a lower future risk of developing Parkinson's disease in male but not in female,^([@B19])^ being consistent with the result of current study.

It has been known that neutrophils, once activated, could release reactive oxygen species, contributing to endothelial damage in cardiovascular disease.^([@B20])^ On the other hand, monocytes are crucial cells in the generation of atherosclerotic lesions, because they, when stimulated, can adhere to endothelium, causing cardiovascular injury.^([@B21])^ Moreover, it has been reported that the oxidative stresses of neutrophils are affected by HbA1c.^([@B22])^ In line with these previous findings, WBC correlated with HNA especially in female. On the other hand, the parameters for red blood cells did correlate with HNA in male but not in female. The link between anemia and oxidative stress may be explained by the aging of hematopoietic stem cells caused by reactive oxygen species, which may result in hematopoietic disorder.^([@B23])^ In male, platelet counts correlated with HNA but not in female, suggesting that hematopoiesis in general may be more susceptible to reactive oxygen species in male than in female.

As to the parameters for liver injury, AST but not ALT and LDH had a link with HNA closer in female. Thus, liver as well as kidney may be one of the important target organs by oxidative stress. In line with this, albumin was shown to be severely oxidized in acute-on-chronic liver failure,^([@B24])^ and HNA was reportedly a prognostic marker in chronic liver failure.^([@B25])^

In conclusion, oxidized, HNA level in serum, measured by a novel method, was approximately 25% in healthy subjects, correlated with age but not with gender, in line with previous reports. Based on the results from regression analyses with clinical parameters, hypertension, obesity, liver injury, renal function, and anemia may be closely associated with oxidative stress.
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###### 

Characteristics of the subjects

                                           All (*n* = 60)   Male (*n* = 30)   Female (*n* = 30)   *p* value
  ---------------------------------------- ---------------- ----------------- ------------------- -----------
  Age                                      63.1 ± 9.9       64.7 ± 9.4        61.4 ± 10.2         0.083
  Human nonmercaptalbumin (HNA) (%)        25.1 ± 3.0       25.1 ± 3.1        25.0 ± 3.2          0.379
  Body Mass Index (BMI) (kg/m^2^)          22.6 ± 3.0       23.5 ± 2.1        21.7 ± 3.6          0.001
  Systolic blood pressure (SBP) (mmHg)     120.2 ± 15.4     120.4 ± 16.3      120.0 ± 14.8        0.471
  Diastolic blood pressure (DBP) (mmHg)    75.6 ± 11.0      74.6 ± 11.8       76.5 ± 10.3         0.273
  Pulse pressure (PP) (mmHg)               44.7 ± 9.6       45.8 ± 10.0       43.5 ± 9.2          0.195
  γ-glutamyltransferase (GGT) (U/L)        28.9 ±21.7       35.6 ± 28.0       22.1 ± 8.6          0.001
  Alkaline phosphatase (ALP) (U/L)         179.7 ± 50.5     171.0 ± 30.3      188.4 ± 64.1        0.095
  Lactate dehydrogenase (LDH) (U/L)        195.8 ± 37.8     188.5 ± 29.7      203.1 ± 43.8        0.127
  Cholineesterase (CHE) (U/L)              316.1 ± 55.1     321.5 ± 40.3      310.8 ± 66.9        0.175
  Aspartate aminotransferase (AST) (U/L)   21.0 ± 4.4       21.8 ± 3.3        20.2 ± 5.2          0.031
  Alanine aminotransferase (ALT) (U/L)     17.6 ± 6.5       19.2 ± 6.0        16.0 ± 6.7          0.008
  Amylase (AMY) (U/L)                      72.8 ± 27.0      73.3 ± 29.6       72.2 ± 24.7         0.436
  Total protein (TP) (g/L)                 6.9 ± 0.3        6.9 ± 0.3         6.9 ± 0.3           0.480
  Albumin (ALB) (g/L)                      4.2 ± 0.2        4.2 ± 0.2         4.1 ± 0.2           0.023
  Total bilirubin (TB) (mg/dl)             0.9 ± 0.2        0.9 ± 0.3         0.9 ± 0.2           0.250
  Creatinine (Cre) (mg/dl)                 0.80 ± 0.19      0.90 ± 0.14       0.69 ± 0.17         \<0.001
  Blood urea nitrogen (BUN) (mg/dl)        14.8 ± 4.0       15.1 ± 3.6        14.5 ± 4.3          0.160
  Uric acid (UA) (mg/dl)                   5.6 ± 1.3        6.3 ± 1.1         4.9 ± 1.3           \<0.001
  Total cholesterol (TC) (mg/dl)           204.7 ± 28.1     200.6 ± 23.0      208.8 ± 32.2        0.140
  Triglyceride (TG) (mg/dl)                97.0 ± 51.2      108.2 ± 58.7      85.9 ± 40.4         0.043
  Iron (Fe) (µg/dl)                        103.4 ± 31.3     109.3 ± 30.1      97.5 ± 31.9         0.147
  C-reactive protein (CRP) (mg/dl)         0.31 ± 1.82      0.08 ± 0.11       0.53 ± 2.58         0.114
  Carcinoembryonic antigen (CEA) (pg/ml)   2.6 ± 1.3        2.7 ± 1.5         2.5 ± 1.2           0.236
  Glucose (GLU) (mg/dl)                    96.1 ± 12.7      98.9 ± 14.2       93.3 ± 10.6         0.077
  Hemoglobin A1c (HbA1c) (%)               5.7 ± 0.4        5.8 ± 0.5         5.6 ± 0.3           0.102
  Red blood cell (RBC) (×10^12^/L)         4.52 ± 0.44      4.67 ± 0.46       4.37 ± 0.38         0.002
  White blood cell (WBC) (×10^9^/L)        5.0 ± 1.2        5.3 ± 1.1         4.6 ± 1.3           0.007
  Platelet (PLT) (×10^9^/L)                224.7 ± 51.1     210.8 ± 37.1      238.6 ± 59.4        0.049
  Hemoglobin (HGB) (g/dl)                  13.9 ± 1.4       14.6 ± 1.1        13.2 ± 1.2          \<0.001
  Hematocrit (HCT) (%)                     41.8 ± 3.7       43.4 ± 3.0        40.1 ± 3.7          0.001

Date are presented as mean ± SD, and compared by Mann-Whitney *U* test.

###### 

Spearman's rank correlation coefficient (rs) between HNA and the categorical variables

          All (*n* = 60)   Male (*n* = 30)   Female (*n* = 30)                       
  ------- ---------------- ----------------- ------------------- -------- ---------- --------
  Age     0.6392           \<0.0001          0.6281              0.0001   0.6154     0.0001
  PP      0.4391           0.0002            0.4003              0.0142   0.5028     0.0023
  AST     0.4047           0.0007            0.1726              0.1809   0.6077     0.0002
  LDH     0.4019           0.0007            0.3512              0.0285   0.4609     0.0052
  BUN     0.3974           0.0008            0.3699              0.0221   0.3962     0.0151
  Cre     0.3714           0.0017            0.5550              0.0007   0.2875     0.0617
  SBP     0.3674           0.0019            0.3476              0.0299   0.4207     0.0103
  UA      0.2901           0.0123            0.1937              0.1525   0.4233     0.0099
  WBC     0.2843           0.0138            0.1517              0.2118   0.3952     0.0153
  BMI     0.2804           0.0150            0.2467              0.0944   0.2850     0.0634
  TG      0.2553           0.0245            0.2810              0.0663   0.2650     0.0785
  HbA1c   0.2447           0.0297            0.2221              0.1191   0.1873     0.1609
  TP      0.2105           0.0532            0.1124              0.2771   0.3366     0.0345
  PLT     --0.1932         0.0695            --0.3255            0.0396   --0.0923   0.3137
  ALT     0.1731           0.0929            --0.0046            0.4904   0.2358     0.1048
  HGB     --0.1419         0.1397            --0.4675            0.0046   --0.0232   0.4515
  HCT     --0.1389         0.1450            --0.3849            0.0178   --0.0716   0.3534
  DBP     0.1232           0.1742            0.1720              0.1818   0.1459     0.2208
  GGT     0.1203           0.1799            --0.0944            0.3099   0.1634     0.1941
  CRP     0.1128           0.1955            0.1448              0.2227   0.0515     0.3934
  Fe      --0.0884         0.2508            0.1467              0.2197   --0.0513   0.3939
  RBC     --0.0841         0.2615            --0.3064            0.0498   --0.0961   0.3067
  CEA     --0.0622         0.3184            --0.0441            0.4085   0.1127     0.2767
  AMY     0.0597           0.3252            0.2240              0.1171   0.1359     0.2370
  CHE     0.0509           0.3497            --0.1234            0.2580   0.2344     0.1062
  TB      --0.0481         0.3575            --0.0961            0.3067   --0.0656   0.3653
  ALP     0.0460           0.3634            0.1220              0.2604   0.0245     0.4489
  GLU     --0.0083         0.4749            --0.1994            0.1454   0.1951     0.1507
  ALB     0.0056           0.4831            0.0024              0.4950   --0.0073   0.4848
  TC      0.0020           0.4940            0.2058              0.1377   --0.1443   0.2234

###### 

HNA according to BMI, blood pressure, and daily habits

                       *n*    HNA (%)      *p* value
  -------------------- ------ ------------ -----------
  BMI                                      
   \<25                50     24.8 ± 3.0   0.098
   ≥25                 10     26.5 ± 3.6   
  SBP                                      
   \<130               46     24.6 ± 3.0   0.013
   ≥130                14     26.7 ± 3.1   
  DBP                                      
   \<85                45     25.0 ± 3.2   0.321
   ≥85                 15     25.4 ± 2.9   
  PP                                       
   ≤50                 46     24.3 ± 2.7   0.002
   \>50                14     27.5 ± 3.2   
  Smoking history                          
   Nonsmoker           39     25.2 ± 3.1   0.293
  Ever smoker/smoker   16/5   24.9 ± 3.3   
  Drinking history                         
   Nondrinker          29     25.1 ± 3.2   0.497
   Drinker             31     25.1 ± 3.1   

Date are presented as mean ± SD, and compared by Mann-Whitney *U* test.
